Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Major Shareholding Notification 2021

Jan 28, 2021

64741_rns_2021-01-28_d6200835-3de1-48d4-86ce-7e9597c15f94.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

604 page 1/2 15 July 2001

Form 604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
604
page 1/2
15 July2001
Form 604
Corporations Act 2001
Section 671B
Notice of change of interests of substantial holder
ToCompany Name/Scheme
Cyclopharm Limited
ACN/ARSN
116 931 250
1. Details of substantial holder (1)
Name
Karst Peak Capital Limited and its associates, Karst Peak Shearwater Master Fund, Vermilion Peak Master Fund, and
Adam Gregory Leitzes
This notice is given by Karst Peak Capital Limited and on its own behalf and on behalf of Karst Peak Shearwater Master
Fund, Vermilion Peak Master Fund, and Adam Gregory Leitzes
ACN/ARSN (if applicable)
N/A
There was a change in the interests of the
substantial holder on
27/01/2021
The previous notice was given to the company on
02/01/2020
The previous notice was dated
02/01/2020
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a
relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
Class of securities (4)
Previous notice
Present notice
Person’s votes
Voting power(5)
Person’s votes
Voting power(5)
Fully Paid Ordinary Shares (FPO)
8,500,000
10.86%
8,906,026
9.70%
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or
scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
Date of
change
Person whose
relevant interest
changed
Nature of
change (6)
Consideration
given in relation
to change (7)
Class and
number of
securities
affected
Person’s votes
affected
07/01/2021
Karst Peak
Shearwater Master
Fund
On-market purchase of
securities
$25,369.60
+ 9,910 fully paid
ordinary shares
+9,910
08/01/2021
Karst Peak
Shearwater Master
Fund
On-market purchase of
securities
$29,670.00
+ 11,500 fully paid
ordinary shares
+11,500
27/01/2021
Karst Peak
Shearwater Master
Fund
Participation in Institutional
Placement announced on
21 January 2021
$1,000,001.6
+ 384,616 fully paid
ordinary shares
+384,616
4. Present relevant interests
Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:
Holder of
relevant
interest
Registered
holder of
securities
Person entitled
to be registered
as holder (8)
Nature of
relevant
interest (6)
Class and
number of
securities
Person’s votes
Karst Peak Shearwater
Master Fund (KPSMF)
HSBC Custody
Nominees (Australia)
Limited (“HSBC”)
HSBC
Owner of ordinary
shares
5,071,676
5.52%
Vermilion Peak Master
Fund (VPMF)
HSBC
HSBC
Owner of ordinary
shares
3,834,350
4.18%
Karst Peak Capital Limited HSBC
HSBC
Discretionary
investment managers
to KPSMF and VPMF
8,906,026
9.70%
Adam Gregory Leitzes
HSBC
HSBC
Shareholder, director
and CIO of Karst Peak
Capital Limited, and
director of KPSMF and
VPMF
8,906,026
9.70%
Cyclopharm Limited
116 931 250
Karst Peak Capital Limited and its associates, Karst Peak Shearwater Master Fund, Vermilion Peak Master Fund, and
Adam Gregory Leitzes
This notice is given by Karst Peak Capital Limited and on its own behalf and on behalf of Karst Peak Shearwater Master
Fund, Vermilion Peak Master Fund, and Adam Gregory Leitzes
N/A
Date of
change
Person whose
relevant interest
changed
Nature of
change (6)
Consideration
given in relation
to change (7)
Class and
number of
securities
affected
Person’s votes
affected
07/01/2021 Karst Peak
Shearwater Master
Fund
On-market purchase of
securities
$25,369.60 + 9,910 fully paid
ordinary shares
+9,910
08/01/2021 Karst Peak
Shearwater Master
Fund
On-market purchase of
securities
$29,670.00 + 11,500 fully paid
ordinary shares
+11,500
27/01/2021 Karst Peak
Shearwater Master
Fund
Participation in Institutional
Placement announced on
21 January 2021

$1,000,001.6
+ 384,616 fully paid
ordinary shares
+384,616
he change are as follows:
Holder of
relevant
interest
Registered
holder of
securities
Person entitled
to be registered
as holder (8)
Nature of
relevant
interest (6)
Class and
number of
securities
Person’s votes
Karst Peak Shearwater
Master Fund (KPSMF)
HSBC Custody
Nominees (Australia)
Limited (“HSBC”)
HSBC Owner of ordinary
shares
5,071,676 5.52%
Vermilion Peak Master
Fund (VPMF)
HSBC HSBC Owner of ordinary
shares
3,834,350 4.18%
Karst Peak Capital Limited HSBC HSBC Discretionary
investment managers
to KPSMF and VPMF
8,906,026 9.70%
Adam Gregory Leitzes HSBC HSBC Shareholder, director
and CIO of Karst Peak
Capital Limited, and
director of KPSMF and
VPMF


8,906,026
9.70%

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name
and
applicable)
ACN/ARSN
(if
Nature of association
N/A N/A
6. Addresses
The addresses of persons named in this form are as follows:
Name Address
Karst Peak Capital Limited and Adam
Gregory Leitzes
H Code, High Block 8thFloor, Suite E, 45 Pottinger Street,
Hong Kong
KPSMF and VPMF c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-
1104, Cayman Islands
HSBC GPO BOX 5302, Sydney NSW 2001, Australia
Signature
print name Andrea Sorani capacity Authorized Signatory
sign here date 29/Jan/2021
DIRECTIONS
(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and
trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar,
they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members
is clearly set out in paragraph 6 of the form.
(2) See the definition of "associate" in section 9 of the Corporations Act 2001.
(3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4) The voting shares of a company constitute one class unless divided into separate classes.
(5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.
(6) Include details of:
  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

  • See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

  • (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.